Zydus Lifesciences announces acquisition of 50% stake in Sterling Biotech's API business
Sep 17, 2024•about 1 year ago
Acquiring Company
Zydus Wellness
Acquired Company
Sterling Biotech Ltd
Description
Zydus Lifesciences has announced a crucial acquisition deal involving the acquisition of 50% stake in Sterling Biotech Ltd's Active Pharmaceutical Ingredients (API) Business. This strategic move aims to expand Zydus's portfolio and leverage SBL's fermentation-based products expertise and manufacturing facility in proximity to Zydus's existing facility.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed